Pete Manetta

Pete Manetta has extensive experience in the healthcare industry, primarily focused on nuclear medicine radiopharmaceuticals. Pete began their career as a Radiologic Technologist at the Hospital for Special Surgery in 1995, where they worked until 1998. Pete then moved on to the Hospital for Special Surgery NJ Satellite Location, where they served as Chief Technologist from 1998 to 2000. Following that, they transitioned to a role as a Telephone Sales Representative/Advertising Consultant at Verizon Information from 2000 to 2001. Manetta then joined Mallinckrodt Pharmaceuticals in 2001 as an Imaging Account Manager/NMBC, where they managed and grew a $12M territory. Pete continued with the company after it was acquired by Covidien in 2008, working as a Nuclear Medicine Specialist until 2010. Manetta then joined Triad Isotopes, which acquired Covidien's Radiopharmacies, as a Sales Director, managing and growing a $20M territory until 2014. Pete then moved to Jubilant Radiopharma, where they served as Director of National Accounts, responsible for developing and managing long-term business relationships and partnerships on a national level.

Pete Manetta holds a BS in Organizational Management from St. Joseph's University New York. Pete also completed a degree in Radiologic Technology with a focus on Diagnostic Imaging from the Long Island School of Radiologic Technology. Additionally, Pete has obtained several certifications, including being a licensed Radiologic Technologist in NY and NJ and completing various sales and negotiation training programs.